Registration
Advertiser Disclosure

Pharmaceuticals, rare diseases, and treatments by Catalyst Pharmaceuticals

Catalyst Pharmaceuticals stock holds steady just below annual high after conference appearance
  • Dan Blystone
  • 27.06.2026
Catalyst Pharmaceuticals stock holds steady just below annual high after conference appearance
Catalyst Pharmaceuticals is present at the International Conference on Children’s Bone Health, the company said in a tweet.Catalyst Pharmaceuticals invited attendees to visit its table for ...
Catalyst Pharmaceuticals stock sees steady action near resistance as CatalystForRare promotes Duchenne event
  • Emilio Ghigini
  • 26.06.2026
Catalyst Pharmaceuticals stock sees steady action near resistance as CatalystForRare promotes Duchenne event
Catalyst Pharmaceuticals announced its participation at ParentProjectMD's PPMD 2026 conference.The event brings together families, patients, caregivers, doctors, researchers, and industry partners ...
Catalyst Pharmaceuticals stock edges higher to 31.41 after patient summit event, CatalystForRare
  • Ciaran Ryan
  • 24.06.2026
Catalyst Pharmaceuticals stock edges higher to 31.41 after patient summit event, CatalystForRare
Catalyst Pharmaceuticals held a recent Patient Summit focused on connection, shared understanding, and community.Patients, caregivers, and ambassadors attended the event. Members of the Patient ...
Catalyst Pharmaceuticals stock trades up to $31.39 as CatalystForRare shares mindfulness advice
  • Dan Blystone
  • 23.06.2026
Catalyst Pharmaceuticals stock trades up to $31.39 as CatalystForRare shares mindfulness advice
Catalyst Pharmaceuticals shares a message from Marissa, Founder and CEO of Team Joseph, about the importance of staying grounded in the moment.The company features Marissa's perspective as part of ...
Catalyst Pharmaceuticals stock holds near $31.38 as CatalystForRare posts Father’s Day message
  • Ciaran Ryan
  • 21.06.2026
Catalyst Pharmaceuticals stock holds near $31.38 as CatalystForRare posts Father’s Day message
Catalyst Pharmaceuticals posted a Father's Day message, expressing appreciation for fathers who protect, teach, and encourage.The company thanked fathers for both the little things and big things, ...
Catalyst Pharmaceuticals stock holds steady at $31.27 after New Directions conference event mention, CatalystForRare posts
  • Dan Blystone
  • 07.06.2026
Catalyst Pharmaceuticals stock holds steady at $31.27 after New Directions conference event mention, CatalystForRare posts
Catalyst Pharmaceuticals is present at the New Directions in Biology and Disease of Skeletal Muscular Conference.The company has invited attendees to visit its table to learn more about Duchenne ...
Catalyst Pharmaceuticals stock edges higher while price consolidates near resistance levels
  • Dan Blystone
  • 02.06.2026
Catalyst Pharmaceuticals stock edges higher while price consolidates near resistance levels
Catalyst Pharmaceuticals is shining a light on myasthenia gravis in a new awareness effort. The company is encouraging participation in the Myasthenia Gravis Association's 'light the globe' ...
2025 results exceed expectations as 2026 outlook set, Catalyst Pharmaceuticals projects
  • Igor Krasulya
  • 12.03.2026
2025 results exceed expectations as 2026 outlook set, Catalyst Pharmaceuticals projects
Catalyst Pharmaceuticals President and CEO Rich Daly, accompanied by members of senior management, participated in the Barclays 28th Annual Global Healthcare Conference. The team presented ...
Catalyst Pharmaceuticals recognized as top workplace for 2026
  • Elena Nikulina
  • 05.11.2025
Catalyst Pharmaceuticals recognized as top workplace for 2026
Catalyst Pharmaceuticals has been named a BioSpace 'Best Place to Work' for 2026. The recognition highlights the company's commitment to creating an enriching work environment. Factors ...
Who We Are
Business Solutions
For Users
TU News
Popular Sections
Disclosures
CONTACT US
Legal
We are in Social Media
© IAFT Ltd., 2010-2026 All rights to the website are owned by IAFT Ltd.,
Registration number - HE 336186
  • Risk disclosure:

    Information on the TradersUnion.com website is for informational purposes only and does not constitute any motive or suggestion to visitors to invest money. Moreover, we hereby warn you that trading on the Forex and CFD markets is always a high risk. According to the statistics, 75-89% of customers lose the funds invested and only 11-25% of traders earn a profit. Trading in futures and options carries substantial risk of loss and is not suitable for every investor.

    That is why you should only invest money that you are prepared — or can afford — to lose at such high risks. Tradersunion.com does not provide any financial services, including investment or financial advisory services. Also, the Traders Union is not a broker and does not get money for trading in the Forex or CFD markets. Our website only provides information on brokers and the markets and helps its users to select the best brokerage company based on detailed information and objective analysis of brokers.

  • Disclaimer:

    Traders Union (TradersUnion.com) shall not be liable for the consequences of trading decisions made by the Client and for the possible loss of his capital resulting from the use of this website and information published on it.

    Forex market, CFD and cryptocurrency trading involves high risks and is not suitable for everyone. Before investing money, you need to adequately assess the level of your expertise and be aware of the risks, particularly in the context of trading with leverage. The information on this website is not intended for distribution or use by any person in any country or jurisdiction, where such distribution or use would be in violation of the local law or regulation. Any payments by Traders Union (TradersUnion.com) to the users of our website shall be legally interpreted solely as an incentive on our part for the activity on the website in the form of a deduction of a part of the advertising income; they shall not be a subject of any claims of our users or our obligations, a subject of disputes, as well as cannot be considered in relation to the services provided to users by brokers, both in fact and in their completeness and volume. The administration of the website shall not be liable for the content of user comments and reviews about the companies and shall not verify whether the authors of the reviews are indeed real clients of a specific company. All reviews, both negative and positive are published on the website without verification of their reliability; only offensive reviews that call for violence or any kind of discrimination and also reviews published from one group of IP addresses are moderated and removed. The authors of the materials shall be fully liable for the accuracy, completeness and impartiality of any information in the articles and reviews, including in the context of their use or mention of any brand names or trademarks. All mentions of the names of companies and their brands in any materials on the website shall be made in the context of communication of socially important information to the people about their activities by independent journalists, who are the authors. All evaluations and indicators on the website express the subjective opinion of the authors of the reviews (articles) and shall not be viewed as accurate statements and be a subject of disputes and claims against Traders Union.

  • Disclosure of advertisers and revenues:

    All the services on the Tradersunion.com website are free for you to use. Our team spends thousands of hours per annum researching brokers and gathering information about them to help investors all over the world to choose reliable companies and to avoid fraudsters.

    Indeed, the curating, sourcing, and organization of this process requires substantial financial investment by Tradersunion.com, which the website earns in the form of advertising payments. There are two types of advertising services on the website — direct advertising or partner (broker) participation programs. However, no services purchased by our partners shall affect the recommendations on our website, or our opinions, or ratings. Our ratings are based on our objective rating criteria and methodology; and the results are always equally and fairly applied to each broker. The work of our content authors and research groups does not involve any interaction with our advertisers and they do not have access to data concerning the amount of advertising purchased. For over 10 years we consider our independence, absolute openness, and objectivity as our main priority. Please follow the links to each of our affiliated broker’s websites. This will help Tradersunion.com to continue to provide our services to you for free.

onepercentfortheplanet.org World Association of News Publishers https://gdpr.eu/ GDPR